U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pathogen: clinical or host-associated sample from Escherichia coli

Identifiers
BioSample: SAMN40930667; Sample name: BWH_1865_E_col; SRA: SRS20993243
Organism
Escherichia coli
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Escherichia
Package
Pathogen: clinical or host-associated; version 1.0
Attributes
isolateBWH_1865_E_col
collected byBrigham and Women's Hospital
collection date2024
geographic locationUSA:Boston
hostHomo sapiens
host diseaseUrinary tract infection
isolation sourceurine
latitude and longitude42.3362 N 71.1067 W
host age28
BioProject
PRJNA278886
Retrieve all samples from this project

Submission
Brigham and Women's Hospital, Jay Worley; 2024-04-11
Antibiogram
AntibioticResistance phenotypeMeasurement signMeasurementMeasurement unitsLaboratory typing methodLaboratory typing platformVendorLaboratory typing method version or reagentTesting standard
amikacinsusceptible<=2mg/LMICVitekBiomérieux96-Well PlateCLSI
amoxicillin-clavulanic acidsusceptible==8/4mg/LMICVitekBiomérieux96-Well PlateCLSI
ampicillinresistant>=32mg/LMICVitekBiomérieux96-Well PlateCLSI
cefazolinresistant>=64mg/LMICVitekBiomérieux96-Well PlateCLSI
cefepimesusceptible==2mg/LMICVitekBiomérieux96-Well PlateCLSI
cefoxitinsusceptible<=4mg/LMICVitekBiomérieux96-Well PlateCLSI
ceftazidimesusceptible==4mg/LMICVitekBiomérieux96-Well PlateCLSI
ceftriaxoneresistant>=64mg/LMICVitekBiomérieux96-Well PlateCLSI
ciprofloxacinsusceptible<=0.25mg/LMICVitekBiomérieux96-Well PlateCLSI
ertapenemsusceptible<=0.5mg/LMICVitekBiomérieux96-Well PlateCLSI
fosfomycinsusceptible==27mmdisk diffusionCLSI
gentamicinsusceptible<=1mg/LMICVitekBiomérieux96-Well PlateCLSI
levofloxacinintermediate==1mg/LMICVitekBiomérieux96-Well PlateCLSI
meropenemsusceptible<=0.25mg/LMICVitekBiomérieux96-Well PlateCLSI
nitrofurantoinsusceptible<=16mg/LMICVitekBiomérieux96-Well PlateCLSI
piperacillin-tazobactamsusceptible<=4/4mg/LMICVitekBiomérieux96-Well PlateCLSI
tetracyclineresistant>=16mg/LMICVitekBiomérieux96-Well PlateCLSI
tobramycinsusceptible<=1mg/LMICVitekBiomérieux96-Well PlateCLSI
trimethoprim-sulfamethoxazoleresistant>=304/16mg/LMICVitekBiomérieux96-Well PlateCLSI
Accession:
SAMN40930667
ID:
40930667

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center